DR6 has also been recognized as an oncogene which is highly expressed in glioma, ovarian cancer, sarcoma, and melanoma (Stegmann et al. 2022; Shi et al. 2018; Yang et al. 2012, 2016). Here, TNFRSF21 is linked to ovarian cancer.